Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers